UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Role of TKI for Metastatic Osteogenic Sarcoma

Current treatment options in oncology, 2020-06, Vol.21 (8), p.65-65, Article 65

Duffaud, Florence

2020

Link zum Volltext

Verfügbarkeit prüfen

Diffusion weighted imaging changes in extra-abdominal desmoid tumor after cryotherapy

Annals of medicine (Helsinki), 2023-12, Vol.55 (1), p.521-525

2023

Link zum Volltext

Verfügbarkeit prüfen

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Cancer, 2020-06, Vol.126 (11), p.2637-2647

2020

Link zum Volltext

Verfügbarkeit prüfen

Regorafenib for the Treatment of Sarcoma

Current treatment options in oncology, 2022-11, Vol.23 (11), p.1477-1502

2022

Link zum Volltext

Verfügbarkeit prüfen

Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial

The lancet oncology, 2018-05, Vol.19 (5), p.639-648

2018

Link zum Volltext

Verfügbarkeit prüfen

Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma

The oncologist (Dayton, Ohio), 2018-01, Vol.23 (1), p.62-70

2018

Link zum Volltext

Verfügbarkeit prüfen

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial

The lancet oncology, 2010-10, Vol.11 (10), p.942-949

2010

Link zum Volltext

Verfügbarkeit prüfen

A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients

Scientific reports, 2017-06, Vol.7 (1), p.2714-11, Article 2714

2017

Link zum Volltext

Verfügbarkeit prüfen

Primary cardiac sarcomas: A retrospective study of the French Sarcoma Group

European journal of cancer (1990), 2014-01, Vol.50 (1), p.128-136

2014

Link zum Volltext

Verfügbarkeit prüfen

Prospective Multicentric Randomized Phase III Study of Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors Comparing Interruption Versus Continuation of Treatment Beyond 1 Year: The French Sarcoma Group

Journal of clinical oncology, 2007-03, Vol.25 (9), p.1107-1113

2007

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in managing gastrointestinal stromal tumor [version 1; peer review: 2 approved]

F1000 research, 2017, Vol.6, p.1689-1689

2017

Link zum Volltext

Verfügbarkeit prüfen

Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy

International journal of radiation oncology, biology, physics, 2018-10, Vol.102 (2), p.399-406

2018

Link zum Volltext

Verfügbarkeit prüfen

Results of API–AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome‐09 study

International journal of cancer, 2020-01, Vol.146 (2), p.413-423

2020

Link zum Volltext

Verfügbarkeit prüfen

Determinants of the access to remote specialised services provided by national sarcoma reference centres

BMC cancer, 2021-05, Vol.21 (1), p.1-12, Article 631

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study

Annals of surgical oncology, 2020-05, Vol.27 (5), p.1693-1699

2020

Link zum Volltext

Verfügbarkeit prüfen

Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies

Journal of clinical oncology, 2010-01, Vol.28 (1), p.160-165

2010

Link zum Volltext

Verfügbarkeit prüfen

Nutritional status and quality of life of cancer patients needing exclusive chemotherapy: a longitudinal study

Health and quality of life outcomes, 2017-04, Vol.15 (1), p.85-85, Article 85

2017

Link zum Volltext

Verfügbarkeit prüfen

EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib

PloS one, 2018-09, Vol.13 (9), p.e0204117-e0204117

2018

Link zum Volltext

Verfügbarkeit prüfen

Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study

Targeted oncology, 2021-07, Vol.16 (4), p.485-492

2021

Link zum Volltext

Verfügbarkeit prüfen

Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile

Cancers, 2020-03, Vol.12 (3), p.583

2020

Link zum Volltext

Verfügbarkeit prüfen

Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin

Cancers, 2019-03, Vol.11 (3), p.432

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 189

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(171)

Publikationsform

Artikel
(189)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Role of TKI for Metastatic Osteogenic Sarcoma

Diffusion weighted imaging changes in extra-abdominal desmoid tumor after cryotherapy

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Regorafenib for the Treatment of Sarcoma

Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial

Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial

Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial

A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

Primary cardiac sarcomas: A retrospective study of the French Sarcoma Group

Prospective Multicentric Randomized Phase III Study of Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors Comparing Interruption Versus Continuation of Treatment Beyond 1 Year: The French Sarcoma Group

Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib

Recent advances in managing gastrointestinal stromal tumor [version 1; peer review: 2 approved]

Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy

Results of API–AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome‐09 study

Determinants of the access to remote specialised services provided by national sarcoma reference centres

Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study

Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies

Nutritional status and quality of life of cancer patients needing exclusive chemotherapy: a longitudinal study

EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib

Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study

Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)

Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile

Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin

Suchergebnisse filtern